27 February 2023
Was last year a tipping point in the transition to digital pharma advertising? A fresh slice of data from Standard Media Index suggests that might be the case, revealing spending on linear TV fell for the first time in years and that digital’s share of the media mix passed 50%.
In recent years, digital has increased its share of the media mix, per SMI’s data, but pharma companies have still been spending more and more on TV spots. That changed in 2022, when spending on TV fell by 4% year on year. Darrick Li, vice president of sales in North America at SMI, outlined how the market is moving in an interview with Fierce Pharma.
“There has been a little bit of a replacement of ad spending dollars on TV with digital. TV is still massive, in our pool it represents $5 billion, which is a huge amount of spend by pharmaceutical advertising, but we've started to see in the last year that the shift is a little bit more pronounced,” Li said. “It's pretty phenomenal that we're seeing that shift happen so quickly.”
Conditions over the past few years have favored digital. When buying linear TV advertising, it is “a little bit harder to be flexible and fluid with the campaign and the commitments,” Li said, creating problems for pharma companies that needed to react to changes such as lockdowns during the pandemic. Last year, digital’s share of the media mix rose from 49.6% to 52.6%, while linear TV fell from 46.4% to 42.9%.
Now, the macroeconomic environment is affecting spending patterns. While SMI’s data for January show pharma companies are continuing to spend more on advertising, even as their counterparts in tech and consumer goods pull back, “maybe they're not making as big of commitments,” Li said, or they’re making bigger upfront commitments to make “sure that they’re getting the most out of their ad spend.”
The fall in spending on linear TV coincided with an increase in investment in long-form digital video, also known as connected TV. Linear TV continues to account for the vast majority of pharma video ad spend, but Li’s data show “a big shift to OTT”—the acronym for over-the-top media services such as Netflix, Hulu and Disney+.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Four cancer centers opened in Russia in 2023
26 April 2024
Russia and the UAE can simplify the drug registration process
26 April 2024
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024